Blood pressure control in a hypertension hospital clinic

Journal of Hypertension

Volumn 17, Issue 6, 1999, Pages 835-841

  Cuspidi, Cesare ^a,b,d   Lonati, Laura ^a,b   Sampieri, Lorena ^a,b   Macca, Giuseppe ^a,b   Valagussa, Laura ^a,b   Zaro, Tiziana ^a,b   Michev, Iassen ^a,b   Salerno, Maurizio ^a,b   Leonetti, Gastone ^c   Zanchetti, Alberto ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d Ctro Fisiol Clinica e Ipertensione   (Italy)

Author keywords

Anti hypertensive treatment; Blood pressure control; Hypertension; Left ventricular hypertrophy

Indexed keywords

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE;

EID: 0032995360     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917060-00016     Document Type: Article

References (23)

1. 1 Hansson L. The optimal blood pressure reduction. J Hypertens 1996; 14 (Suppl. 2):S55-S59.
2. 2 Kannel WB, Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275:1572-1576.
3. 3 Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P. et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys 1960-1991. Hypertension 1995; 26:60-65.
4. 4 The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2442.
5. 5 Mancia G, Sega R, Milesi C, Cesana S, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997; 348:454-457.
6. 6 Colhoun HM, Doug W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England. J Hypertens 1998; 16:747-752.
7. 7 Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertensives: results from the primary prevention trial in Goteborg, Sweden. J Hypertens 1985; 3:167-176.
8. 8 Lindholm L, Ejertsson G, Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. Acta Med Scand 1984; 216:251-259.
9. 9 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man, anatomic validation of the method. Circulation 1977; 55:613-618.
10. 10 Hammond I, Devereux R, Alderman M, Lutas E, Spitzer M, Crowley J, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7:639-650.
11. 11 Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24h intra-arterial blood pressure. Hypertension 1992; 20:227-232.
12. 12 Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390.
13. 13 Staesson JA, O'Brien ET, Amery AK, Atkins N, Baumgart P, De Cort P, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens 1994; 12 (Suppl. 7):S1-S12.
14. 14 1993 Guidelines for the Management of Mild Hypertension. Memorandum from a WHO-ISH Meeting. Bull WHO 1993; 71:503-517.
15. 15 Chatellier G, Menard J, Devries C, Plouin PF, Regoulet P, Corvol P. Blood pressure control in a hypertension center. J Hypertens 1987; 5 (Suppl. 5):S47-S49.
16. 16 Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.
17. 17 Zanchetti A. Contribution of fixed low-dose combinations to initial therapy in hypertension. J Hypertens (in press).
18. 18 Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effect of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; ii:695-697.
19. 19 Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24 hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
20. 20 Prisant LM, Carr AA. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass. Am J Hypertens 1990; 3:81-89.
21. 21 Mancia G, Zanchetti A, Agabiti Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95:1464-1470.
22. 22 Levy D, Garrison R, Savage D, Kannel W, Castelli W. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med 1990; 322:1561-1566.
23. 23 Devereux RB. Importance of left ventricular mass as a predictor of cardiovascular morbidity in hypertension. Am J Hypertens 1989; 2:630-634.